For instance, it is conceivable that pancreatic beta cells are less able to compensate for insulin resistance in CKD (and other muscle-wasting states) than in obesity [9], perhaps because of harmful effects of uraemic retention molecules on the insulin secretion from pancreatic beta cells [95]. The gene discussed is INS; the disease is Insulin resistance.